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Objective. Histopathology of parotid gland tumors is extremely varied and complex due to heterogeneous cellular composition.
Preoperative diagnostic tools include fine needle aspiration cytology, the role of which remains controversial. The aim of this
paper is to evaluate the usefulness and accuracy of fine needle aspiration cytology (FNAC) in the diagnosis of parotid gland
tumors. Methods. We retrospectively reviewed charts of 129 patients who underwent parotidectomy for parotid lesions at Aga Khan
University Hospital from 2002 to 2010. We compared the results of preoperative FNAC with final histopathological diagnosis.
Results. Concordance with histological results was observed in 86%, specificity was 98%, sensitivity was 84%, and diagnostic
accuracy was 94%. Conclusion. Our results demonstrate that preoperative cytology in parotid lesions is fairly accurate and useful
in diagnosing benign from malignant and in planning appropriate approach for treatment.

1. Introduction
A lump in the salivary gland region often presents as a
diagnostic challenge with regards to its site of origin, benign
or malignant. Most of these occur in the parotid glands;
small percentages occur in the submandibular, sublingual,
and minor salivary glands. Parotid gland lesions are a
histologically diverse group. Tumors of this region comprise
3% of all head and neck and 0.6% of all tumors of human
body [1].
The history of fine needle aspiration cytology (FNAC)
goes back to the 1920s where it came into use simultaneously
in Europe and the United states [2, 3]. FNAC is a cytodiagnostic method based on the morphological findings of
individual cells, group of cells, and microparticles of tissue,
acquired using a needle. The role of FNAC for the diagnosis
of salivary gland masses is well documented. The traditional
open biopsy is no longer justified because of the risk of tumor
spillage and damage to the facial nerve [4]. The method has a
high degree of sensitivity in distinguishing the tumors from
nonneoplastic lesions of salivary gland [5, 6].

FNAC is an easily done procedure with minimal incidence of complication and no risk of implantation of tumor
cells (<1%). The complications are rare and bleeding or
inflammatory reaction in the region of the puncture. The
impairment of the involved nerves has been reported as a
very rare complication [7, 8]. FNAC has its proponents and
opponents. It is regarded as a diagnostic procedure to be
superior to the combination of physical examination and
radiological evaluation [9, 10]. Many authors claimed that
it is accurate, safe and cost eﬀective [11–13]. It can also be
performed in children older than seven years [14]. However,
Batsakis and colleagues were of the opinion that preoperative
FNAC has little influence on the clinical management since
most of the parotid masses ultimately require surgery [15].
This point of view ignores a considerable number of benign
salivary tumors that do not necessitate surgery.
Because of the distinct morphology of parotid gland, the
eﬀectiveness of FNAC in its interpretation is still considered
controversial. However, the use of FNAC helps to distinguish
between reactive inflammatory process, which may not
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require surgery, and neoplastic lesions, between benign and
malignant thus allowing proper planning before embarking
any treatment. Surgical planning is dependent on clinical
and radiological investigations; however, if the pathology is
known preoperatively it is easy to counsel the patient and
plan surgery. It is here where FNAC is of help specially for
malignant lesions. In this article we describe our experience
of using FNAC in the preoperative evaluation of parotid
lesions.

2. Material and Methods
A retrospective review was carried out of medical records of
patients that underwent parotidectomy for various pathologies between 2002 to 2010. A total of 205 parotid surgeries
were performed during this period. Of these, only 129
patients were included in this study in which preoperative
FNAC was done at our institution exclusively. Rest of the
patients, in which we only performed surgery but FNAC was
not carried out at our centre, were excluded.
FNAC was performed at our pathology department using
a 22-gauge needle attached to a 10 mL syringe holder by a free
hand technique. A minimum of two needle passes were made
in each case. The specimens were expelled onto two or three
slides, and thin smears were prepared between two slides
and immediately fixed. The slides were generally stained with
Papanicolaou and occasionally with May-Grunwald Giemsa
methods. None of the FNAC was carried out with ultrasonography.
We classified our FNAC results into the following
categories: true-negative (absence of malignancy correctly
diagnosed), true-positive (presence of malignancy correctly
diagnosed), false-negative (cytological specimen failed to
diagnose a malignancy), and false-positive (cytological specimen was incorrectly considered or suspect for malignancy).
We also compared the histopathology of the surgical
specimens with the preoperative cytology of the FNAC
specimens and evaluated the sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV), and
overall accuracy of FNAC to diﬀerentiate between benign and
malignant disease.

3. Results
There were 73 males and 56 females patients. The age range
was 15 to 78 years with a mean age of 44 years. The final
histological diagnoses of the included cases are listed in
Table 1.
There were 98 benign lesions (89 neoplastic and 9
nonneoplastic) while 31 (24%) were malignant tumors
(Table 2). Pleomorphic adenoma was the most common in
benign tumor group (60%) while mucoepidermoid carcinoma (12%) in the malignant group. The FNAC smears were
nondiagnostic in 5 (3.8%) cases, of which 4 were reported
benign (2 neoplastic and 2 nonneoplastic) and 1 malignant
lesion on final histopathology.
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Table 1: Histological diagnosis.
Pleomorphic adenoma
Warthin’s tumor
Sialadenitis
Monomorphic adenoma
Tuberculosis
Cyst
Lymph nodes
Myoepithelial carcinoma
Squamous cell carcinoma
Salivary duct carcinoma
Carcinosarcoma
Metastatic melanoma
Mucoepidermoid carcinoma
Adenoid cystic carcinoma
Acinic cell carcinoma
Lymphoma
Malignant mixed tumor
Total

77
11
6
1
1
1
1
1
1
1
1
1
16
4
3
2
1
129

Table 2: Histological and cytological diagnosis.

Pleomorphic adenoma
Warthin’s tumors
Sialadenitis
Monomorphic adenoma
Tuberculosis
Cyst
Lymph nodes
Total (Benign)
Myoepithelial carcinoma
Sq cell carcinoma
Salivary duct carcinoma
Carcinosarcoma
Metastatic melanoma
Mucoepidermoid carcinoma
Adenoid cystic carcinoma
Acinic cell carcinoma
Lymphoma
Malignant mixed tumor
Total (Malignant)
Total

Histology
77
11
6
1
1
1
1
98 (76%)
1
1
1
1
1
16
4
3
2
1
31 (24%)
129

Cytology discordant
4 (5%)
2 (2%)
3 (50%)
1
1
1
12 (12%)

1
1
2 (1%)
1
1 (50%)
1
7 (22%)
19 ( 14%)

An overall of eighty-five percent (110/129) concordance
between FNAC and final histological diagnosis was established, 78% with malignant and 88% with benign cases
on break up (Table 2). The cytological diagnosis was truepositive in 26 (20%) cases and true-negative in 96 (74%)
cases. Twenty-four of the 26 (92%) true-positive neoplasms
and 86 of the 96 (90%) true-negative benign lesions were
determined as an accurate results (Tables 3 and 4). There
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Table 3: True-positive with accurate and inaccurate results n = 26.
True positive (n = 26)
Accurate (n = 24)

Cytologic diagnosis
14 Mucoepidermoid
4 Adenoid cystic ca.
2 Acinic cell ca.
1 Myoepithelial ca.
1 Squamous cell ca.
1 Lymphoma
1 Metastatic melanoma

Inaccurate (n = 2)
Cytologic diagnosis
Histologic diagnosis
1 Myoepithelial ca.
1 Salivary duct ca.
1 Mucoepidermoid ca.
1 Acinic cell ca.

Histologic diagnosis
14 Mucoepidermoid
4 Adenoid cystic ca.
2 Acinic cell ca.
1 Myoepithelial ca.
1 Squamous cell ca.
1 Lymphoma
1 Metastatic melanoma

Table 4: True-negative with accurate and inaccurate results n = 96.
True-negative (n = 96)
Accurate (n =
Cytologic diagnosis
73 Pleomorphic adenoma
9 Warthin’s tumor
1 Cyst
3 Sialadenitis

86)
Histologic diagnosis
73 Pleomorphic adenoma
9 Warthin’s tumor
1 Cyst
3 Sialadenitis

were 2 (1.5%) false positive and 5 (3.8%) false negative
results (Table 5).
A statistical analysis of 129 cases was carried out to assess
the diagnostic accuracy of parotid FNAC compared with
that of histological results (Table 6). A sensitivity of 84%
was observed. The specificity was 98%, and the diagnostic
accuracy was 94%. The positive and negative predictive
values were 93% and 95%, respectively.
Local inflammation was observed in only two cases
after performing FNAC; however, no complication such as
hematoma, infection, or facial nerve damage was observed.

4. Discussion
The FNAC has been widely used as a diagnostic tool for the
management of various head and neck lesions [16]. Many
authors considered FNAC a superior modality and claimed
it accurate and safe [6, 11–13]. In contrast, others argued
that it has little influence on clinical management because
of its high rates of false-positives and false-negatives and also
ultimately patients have to undergo surgery [15]. However,
the preoperative cytology helps to the diﬀerential diagnosis
between benign and malignant lesions of parotid gland, and
thus the extent of the surgery can be planned and modified
accordingly.

Inaccurate (n = 10)
Cytologic diagnosis
Histologic diagnosis
3 Pleomorphic adenoma
1 Sialadenitis
1 TB
1 Monomorphic adenoma
2 Lymphadenitis
1 Pleomorphic adenoma
1 Lymph nodes
4 Non-neoplastic
2 Sialadenitis
1 Warthin’s tumor
1 Pleomorphic adenoma
1 Sialadenitis
1 Warthin’s tumor

The diagnostic sensitivity of cytopathology in detecting
malignant disease was 84% in this study. This result implicates that if FNAC is used as a screening tool in this patient
group, 12% of the malignant lesions would have been missed.
These values fall within wide range of sensitivity reported in
various studies, from as low as 27% up to 97% [9, 16–21].
The reason often cited for this wide range is the dependence
on skills of the cytotechnologist performing FNAC and the
expertise of the pathologist to assess adequacy and accurate
examination of the specimen.
Specificity in our study was 98%. Specificity reported in
the literature has been similarly high, in the range of 84%
to 100% [9, 16]. The false negative FNAC results included a
variety of lesions. A common reason for false negative FNAC
findings is sampling error.
In the recent literature, the accuracy has ranges from 84%
to 97% [9, 16, 22]. In our study it was 94%. The major
drawback of the FNAC is the occurrence of nondiagnostic
aspirations, which occur in 5 to 15% of cases in literature.
In our study, only 5 (3.8%) aspirates were found to be nondiagnostic results. Failure to obtain a representative smear
could be the result of needle positioning outside the target
tissue or of necrosis, hemorrhage, or cystic areas in the
tumor. In order to decrease chances of these errors and to
increase the diagnostic accuracy various authors [23, 24]
have utilized ultrasonography to assist FNAC but in our
series it was not used.
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Table 5: False Positive and Negative results.

False-negative (n = 5)
Cytologic diagnosis
Histologic diagnosis
1 Pleomorphic adenoma
1 Malignant mixed tumor
1 Cyst
1 Mucoepidermoid ca.
1 Warthin’s tumor
1 Carcinosarcoma
1 Non-neoplastic
1 Mucoepidermoid ca.
1 Lymphadenitis
1 Lymphoma

Table 6: Comparison of histological results in 129 cases with
preoperative cytology results.

FNAC Diagnosis
Total

Benign
Malignant

Histological diagnosis
Benign
Malignant
96 TN
5 FN
2 FP
26 TP
98
31

Total
101
28
129

TN = true-negative, TP = true positive, FN = false negative, and FP = false
positive.

Because of the varied, complex and overlapping morphological features, the diagnosis of pleomorphic, monomorphic
adenoma, and adenoid cystic carcinoma can be sometimes
problematic. We had one case of monomorphic adenoma
which was reported pleomorphic on FNAC. Similarly a case
of carcinosarcoma was labelled as Warthin’s tumor by FNAC
(Table 5). The rate of false negative results was 3.8% in our
review which is significantly less than what Zurrida et al.
[9] and others have reported [16, 25]. Two pleomorphic
adenoma were misinterpreted by FNAC and diagnosed as
mucoepidermoid and myoepithelial carcinoma. This could
have happened because of lack of typical features and the
presence of atypical squamous cells on FNAC [26].
We correctly typed pleomorphic adenoma in 73 of 77
(95%) cases, better than the reported ranges from 82 to
94% in the literature [9, 27]. Mucoepidermoid carcinoma,
according to Cohen et al. [28] is one of the most challenging
lesions to diagnose and type cytologically. However, in our
series 14 out of 16 were correctly classified. The two acinic
cell and 4 adenoid cystic carcinoma were also correctly
recognized in our series.
According to the experience of Shaha et al. [29] the
diagnosis of the malignant lymphoma using the aspirated
cytology is possible. Zurrida et al. [9] reported correct
identification of only 2 of 7 cases of parotid lymphoma
by FNAC while in a series of Al-Khafaji et al. [30], all ten
lymphomas were accurately identified. In our study we were
able to diagnose correct only 1 lymphoma of two cases.
The fact that it was not detected as malignant on FNAC is
consistent with other reports that lymphoma is diﬃcult to
diagnose by FNAC [31] and if a lymphoma is suspected on
clinical grounds, flow cytometry of FNAC can be an adjunct
in diagnosing it.
Still, to some authors, role of FNAC in the diagnosis of
parotid lesions has not been well taken [32]. The only relative

False-positive (n = 2)
Cytologic diagnosis
Histologic diagnosis
1 Myoepithelial ca.
1 Pleomorphic adenoma
1 Mucoepidermoid ca.
1 Pleomorphic adenoma

contraindication of the performing the FNAC could be the
hemorrhagic disease. Many authors exclude the possibility
of the implantation of the malignant cells or its recurrence
caused by FNAB [33]. The phenomenon of tumor cells
seeding has become a rare complication with the current
use of small-bored needles [34]. We only had two cases
of FNAC postprocedure local inflammation which resolved
subsequently. No other complications such as hematoma,
nerve damage, or infection was observed in our series.
The most important questions to be answered by this
study is whether results gained from FNAC can be useful in
the clinical management of patient with parotid lesions. Our
experience has demonstrated a variety of circumstances in
which such data may be valuable. The usual recommendation for the neoplastic lesions regardless of the preoperative
cytological diagnosis is excision but recognition of benign
lesion, beforehand like in case of Warthin’s tumor, in poor
risk patients may be of benefit in avoiding inappropriate
surgery.

5. Conclusion
Our study shows that preoperative FNAC plays an important
role in the accurate diagnosis of parotid tumors. It is a
safe and eﬀective modality for the treatment of patients
with parotid lesion. This oﬃce based procedure is reliable,
well tolerated, easy to perform and cost eﬀective. Moreover
preoperative diﬀerentiation of tumors may help prepare
both the surgeon and patient for an appropriate surgical
procedure.
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